BREDININ TREATMENT IN CLINICAL KIDNEY ALLOGRAFTING
- 31 July 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 38 (2) , 116-118
- https://doi.org/10.1097/00007890-198408000-00005
Abstract
Bredinin, a new nucleoside antibiotic isolated from Eupenicillium brefeldianum, and steroids were used as immunosuppressive agents in 31 renal transplant patients; 17 of them received grafts from living-related donors and 14 from cadavers. The one-year graft survival rates were 100% in renal recipients from living donors and 69.2% in cadaver kidney recipients. There was no serious complication from the use of these immunosuppressive agents.This publication has 1 reference indexed in Scilit: